Meet
Rebecca Snow

Authored Content

February 12, 2021 | Insights & Analysis > COVID-19 Intel Center

mAb Utilization for COVID-19 Remains Low, Despite Availability
Since the beginning of the Public Health Emergency (PHE), manufacturers have been developing monoclonal antibodies (mAbs) and other treatment modalities to prevent and treat COVID-19.